CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells

Lignende værker

• Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
  af: Braciak, Todd A., et al.
  Udgivet: (2018)
• P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
  af: Fey, G, et al.
  Udgivet: (2014)
• Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells
  af: Roskopf, Claudia C., et al.
  Udgivet: (2016)
• NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2
  af: Braciak, Todd A, et al.
  Udgivet: (2013)
• T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell
  af: Roskopf, Claudia C., et al.
  Udgivet: (2014)